COSRX posts double-digit growth in first half on structural reforms, overseas expansion

Derma cosmetic brand COSRX is continuing its robust growth trajectory, following a strong fourth quarter last year into the first half of this year with double-digit sales growth. The company announced on the 26th that the rebound initiated in the fourth quarter of last year has persisted through the first and second quarters of this year. Notably, COSRX achieved its highest monthly sales in May, marking a successful return to profitability.

Company officials attribute this success to intensive structural reforms, including optimizing its global distribution network and logistics, and refining its pricing policies. These efforts have secured growth momentum in overseas markets and rapidly improved the company's constitution. Since its founding in 2013, COSRX has consistently targeted overseas beauty markets, establishing itself as a global derma skincare brand. Despite facing challenges in distribution and pricing management during its rapid growth phase, the company underwent a major overhaul last year, streamlining its distribution structure, enhancing global logistics efficiency, and stabilizing prices both domestically and internationally.

Recent sales performance has been particularly strong in North America and Europe. In the United States, sales of new products, especially the 'Peptide Line' including the 'Peptide Eye Patch', a popular item on TikTok Shop, have expanded, driving growth alongside existing 'Snail Line' products. In Europe, the 'Ultra-Light Invisible Sun Serum' became a bestseller on Amazon in the UK and Germany within the sunscreen category, proving the brand's competitiveness. It is recognized for leading a generational shift in K-beauty sun care, becoming a bestseller in stringent European sunscreen markets against global beauty brands.

"Sales of the peptide line and sun serum, which are driving growth in North America and Europe, continue to be strong," said a COSRX representative. "With diversified growth engines beyond our traditional snail line-based business structure, we anticipate continued growth in the future."

“

Sales of the peptide line and sun serum, which are driving growth in North America and Europe, continue to be strong. With diversified growth engines beyond our traditional snail line-based business structure, we anticipate continued growth in the future.